SIM
ANIK icon

Strategic Investment Management’s Anika Therapeutics ANIK Stock Holding History

Strategic Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,494
Closed -$223K – 112
2014
Q4 		$223K Sell
5,494
-282
-5% -$11K 0.06% 62
2014
Q3 		$211K Sell
5,776
-364
-6% -$15.7K 0.06% 68
2014
Q2 		$284K Buy
+6,140
New +$273K 0.07% 38

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Strategic Investment Management's ANIK Position: Q1 2015 in Review

Strategic Investment Management sold out of Anika Therapeutics (ANIK) in Q1 2015, closing a stake of 5,494 shares — an estimated $223K sold.

Strategic Investment Management first reported a position in ANIK in Q2 2014 and held it in 3 quarters. The position peaked at $284K in Q2 2014. 159 funds tracked by Wall St. Rank hold ANIK as of Q1 2015.

  • Strategic Investment Management reported no remaining Anika Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Strategic Investment Management sold 5,494 Anika Therapeutics shares in Q1 2015, an estimated $223K.
  • Strategic Investment Management first reported a position in Anika Therapeutics in Q2 2014 and held it in 3 quarters.
  • Strategic Investment Management's Anika Therapeutics position peaked at $284K in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2015.

Based on Strategic Investment Management's 13F filing for Q1 2015, filed 14 May 2015.